Associate Director, Search & Evaluation

Novo Nordisk•Cambridge, MA

3d•Hybrid

About The Position

The Novo Cambridge location is the headquarters for Global Business Development across all of our therapeutic and technology areas. We contribute to innovation in one of the world's largest life sciences ecosystems by participating in events and discussions with renowned and upcoming scientists looking for the next scientific breakthrough to bring transformative treatments to patients. We work with start-ups, established companies and venture capitalists to support the development of innovation for mutual benefit, and to help patients in all of our current therapy areas. Through a variety of partnership models, we accelerate ideas from the lab and clinic to advance and expand our product portfolio and to improve outcomes for the patients we serve. Global Business Development is responsible for Novo corporate business development activities related to establishing external partnerships, collaborations and acquisitions, as well as integration and alliance management. The Group Vice President (GVP) area consists of units covering business development from end-to-end with Search, Evaluation & Intelligence, BD and M&A Transactions, Integration and Alliance Management. Search, Evaluation & Intelligence (SE&I) is part of GBD and acts as the primary entry point for external drug and technology opportunities relevant to Novo. SE&I conducts proactive scouting campaigns to identify relevant opportunities by targeting universities, biotechnology companies and venture capital firms, by means of partnering events, road shows and commissioned meetings or events. The search for novel therapeutics focuses on our core areas: diabetes, obesity, as well as MASH, CVD CKD and rare blood and endocrine disorders. Besides our therapeutic areas of interest, SE&I supports the identification of cutting-edge enabling technologies within oligonucleotides, protein and peptide engineering and gene editing/therapy. Working cross-functionally, SE&I supports the assessment of such external opportunities all the way to due diligence and contractual negotiation. The role is a driver for change in executing Novo strategy and business development activities on a global scale.

Requirements

Master’s degree in business or life sciences is required; a medical degree is preferred
8+ years of experience in R&D Business development, or equivalent role
Proven project management skills and experience
Solid knowledge of or experience in clinical drug development in relevant therapeutic areas is an advantage
Ability to analyse and digest complex ideas and data to make clear and qualified recommendations to senior stakeholders
Experience working as part of cross-functional teams, ensuring clear communication and teamwork
Strong communication skills, both in written and presentation form
Outgoing with strong networking, collaboration and stakeholder management skills
Curious, self-driven, solution- and goal-oriented individual who functions well in a dynamic environment
Strategic business and financial acumen coupled with deep interest and curiosity about life sciences and medicine

Responsibilities

Identification of novel pipeline assets and enabling technologies.
Strategic overview of internal, as well as BD, pipeline assets.
Evaluation of novel pipeline assets and enabling technologies.
Contribute to and support identification of novel pipeline assets and enabling technologies
Drive in-depth evaluation and due diligence process
Establish Novo as the preferred partner within relevant therapy areas
Provide support to Business Development during negotiation of licenses and collaborations in alignment with SE&I
Work cross-organizationally with stakeholders from R&D to Commercial and beyond to ensure alignment
Build and maintain BD opportunity landscapes
Actively engage with external stakeholders particularly venture capital, biotech companies and other large-cap pharma
Participate in partnering events, scientific conferences and other relevant networking events